ASX Announcements
PME HY Results release date and webcast briefing
Notification of Results/Reporting Date, Web Casts
- Jan 21, 2025
- 1 page
Market Sensitive
PME signs A$33M, 9-year contract with University of Kentucky
Progress Report
- Jan 16, 2025
- 3 pages
Market Sensitive
PME signs A$15M, 5-year Visage Archive deal with Duke Heath
Progress Report
- Dec 30, 2024
- 2 pages
Market Sensitive
PME signs A$30M, 7-year contract with Duly Health and Care
Progress Report
- Dec 23, 2024
- 2 pages
December 2024
The stocks that did the most damage in 2024 – and the ones that ruled
One fintech darling has more than tripled in the past 12 months, but the same can’t be said for lithium stocks on the front line of the EV slowdown.
- Joshua Peach and Joanne Tran
- Opinion
- Shares
The ASX’s founders are in dump mode
Insiders are cashing out hundreds of millions of dollars of stocks after stellar share price runs. Are they sending a message?
- Jonathan Shapiro
Pro Medicus billionaires in $500m sell-down
The trade crossed the screen in two lines on Tuesday afternoon, with about 2 million shares changing hands at last price.
- Sarah Thompson, Kanika Sood and Emma Rapaport
November 2024
- Opinion
- Chanticleer
Rocket stock Pro Medicus redefines what’s possible
The medical software company is the sort of investment that makes you glad your job does not decide on picking whether it is a market winner or loser.
- Anthony Macdonald
Five founders keeping the faith with investors
Corporate Australia has recently experienced a founder “killing season”, but these founder-led companies are still keeping shareholders happy.
September 2024
Do you know this week’s news? Answer these 10 questions
Have you been paying attention this week? Test your knowledge across politics, business and world news.
- Daniel Arbon
Pro Medicus’ billionaire boss says simplicity secret of success
Pro Medicus’ stranglehold on cloud-imaging healthcare tech means its growth trajectory has a long way to go.
- Michael Smith
Why these tech companies’ M&A plans have stalled
It’s a tough environment for tech companies wanting to buy assets and grow. The disconnect between public and private markets is making it worse.
- Tess Bennett
August 2024
Why tech bolters are lighting up reporting season
WiseTech, Pro Medicus, Life 360 and REA Group have turned heads this season as tech proves the sweet spot for growth investors again.
- Tom Richardson
Pro Medicus share surge defies growth warning
Shares in market darling Pro Medicus jumped on the company’s latest bumper profit, but its CEO says that level of growth will be difficult to maintain.
- Updated
- Michael Smith
- Results Wrap
- Chanticleer
Winners from profit season’s big Wednesday
All eyes were on CBA’s monster numbers, but Seven Group Holdings and AGL also delivered nice profit growth – and Pro Medicus impressed yet again.
- James Thomson and Anthony Macdonald
July 2024
- Exclusive
- Rich Bosses
Nation’s richest boss ‘can’t find anything to invest in’ but WiseTech
This year’s list is stacked with tech founders such as Richard White – and shows how divorces can force bosses down the ranks.
- Patrick Durkin and Sally Patten
The 10 wealthiest executives in the ASX 300 revealed
The Australian Financial Review’s Rich Bosses list for 2024 is dominated by tech and mining executives and also welcomes a new face.
- Euan Black
- Exclusive
- Rich Bosses
The secrets to becoming a rich boss
There are good reasons why tech companies dominate this year’s Rich Bosses list.
- Patrick Durkin and Sally Patten
June 2024
The five best-performing stocks this financial year
A healthcare software developer has narrowly beat a family monitoring app to be the top-performing stock in 12 months.
- Joshua Peach
The top 20 stocks by dividend return this year
Insurers, miners and fund managers were the top performers, but experts warn of income traps.
- Lucy Dean
- Opinion
- Sharemarket
Aussie tech stocks that could supercharge a portfolio
These seven companies have collectively returned an astonishing 1151 per cent since 2016.
- James Weir
May 2024
The ASX business so good ‘you can’t put a sell on it’
Analysts say Pro Medicus is one of the world’s most expensive stocks, but also one of the best.
- Yolanda Redrup
April 2024
- Opinion
- Chanticleer
12 stock picks for a tough investing environment
Low rates and endless stimulus may have left investors unprepared for the difficult environment that lies ahead. Here are 12 stock picks to consider.
- James Thomson
Why Paradice is backing Seven Group’s bid for Boral
Mid-cap investor Jovana Gagic says Kerry Stokes’ conglomerate has a good track record in buying controlling stakes, and reveals why she’s bullish on Orica and Pro Medicus.
- Joanne Tran